2. Search Result
Search Result
Results for "

OMP

" in MedChemExpress (MCE) Product Catalog:

12

Inhibitors & Agonists

9

Inhibitory Antibodies

6

Recombinant Proteins

1

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99401
    Rosmantuzumab

    OMP-131R10

    		 Wnt Cancer
    Rosmantuzumab (OMP-131R10) is an anti-R-spondin 3 (RSPO3) humanized monoclonal antibody. Rosmantuzumab can be used for the research of advanced telapsed and refractory solid tumors .
    Rosmantuzumab
  • HY-P99320
    Tarextumab

    OMP 59R5; Anti-Human NOTCH2 Recombinant Antibody

    		 Notch Cancer
    Tarextumab (OMP-59R5) is an anti-Notch2/3 fully human IgG2 monoclonal antibody. Tarextumab shows anti-tumor activity .
    Tarextumab
  • HY-P9974
    Vantictumab
    1 Publications Verification

    OMP-18R5

    		 Wnt Cancer
    Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab can be studied against cancers through direct actions on tumor cells, including CSCs, and effects on the stroma, such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma .
    Vantictumab
  • HY-P99261
    Demcizumab

    OMP 21M18

    		 Notch Cancer
    Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models .
    Demcizumab
  • HY-P99377
    Navicixizumab

    OMP-305B83; Anti-DLL4 Reference Antibody (navicixizumab)

    		 Notch Cancer
    Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer .
    Navicixizumab
  • HY-P99667
    Ipafricept
    2 Publications Verification

    OMP-54F28; FZD8-Fc

    		 Wnt Cancer
    Ipafricept (OMP-54F28; FZD8-Fc) is a first class recombinant fusion protein with the extracellular part of the human frizzled-8 receptor fused to a human IgG1 Fc fragment that binds Wnt ligands, which blocks Wnt signaling. Ipafricept reduces tumor growth and results in a decrease in both liver and lung metastases combined with Gemcitabine (HY-17026) in pancreatic cancer mouse models. Ipafricept shows solid tumor inhibition activity with well tolerance, such as desmoid tumor, germ cell cancer, ovarian cancer .
    Ipafricept
  • HY-P99258
    Brontictuzumab

    OMP 52M51; Anti-Human NOTCH1 Recombinant Antibody

    		 Notch Cancer
    Brontictuzumab (OMP 52M51) is a monoclonal antibody (MAb) that inhibits Notch1 signal. Brontictuzumab selectively binds the negative regulatory region of the Notch1. Brontictuzumab inhibits tumor cell proliferation. Brontictuzumab can be used in the research of leukemia and lymphoma .
    Brontictuzumab
  • HY-RS09784
    OMP Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    OMP Human Pre-designed siRNA Set A contains three designed siRNAs for OMP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    OMP Human Pre-designed siRNA Set A
    OMP Human Pre-designed siRNA Set A
  • HY-RS16985
    Omp Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Omp Mouse Pre-designed siRNA Set A contains three designed siRNAs for Omp gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Omp Mouse Pre-designed siRNA Set A
    Omp Mouse Pre-designed siRNA Set A
  • HY-RS23428
    Omp Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Omp Rat Pre-designed siRNA Set A contains three designed siRNAs for Omp gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Omp Rat Pre-designed siRNA Set A
    Omp Rat Pre-designed siRNA Set A
  • HY-146412
    Vanin-1-IN-3

    		Pantetheinase Metabolic Disease
    Vanin-1-IN-3 (OMP-7) is a vanin-1 inhibitor with an IC50 of 0.038 μM .
    Vanin-1-IN-3
  • HY-162672
    Antibacterial agent 231

    		Bacterial Infection
    Antibacterial agent 231 (derivative 8) is an antimicrobial agent against multidrug-resistant Helicobacter pylori (H. pylori) with a minimum inhibitory concentration of 0.25–0.5 μg/mL. Antibacterial agent 231 directly targets the protein transposase subunit SecA and the outer membrane protein assembly factor BamD to inhibit the trafficking and assembly of bacterial outer membrane proteins (OMPs). Antibacterial agent 231 can be used to study the effects of antibiotic treatment on intestinal microbial balance .
    Antibacterial agent 231

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: